Prevalence of hypertension is high in the Caribbean while control of hypertension is low. Intervention trials are needed to establish low cost, sustainable approaches that work in this region.
Hypertension is an important risk factor for cardiovascular disease in the Caribbean and globally. It is responsible for 51% of deaths due to cerebrovascular disease (stroke) and 45% of deaths due to ischaemic heart disease, which are the leading causes of death in the Caribbean. The prevalence of hypertension in the Caribbean is high, affecting 21% of adults in Barbados and Trinidad and Tobago, 25% in Jamaica, and 35–38% in St Kitts, British Virgin Islands and Grenada, contributing to the large economic burden from this condition and its complications.